COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy. Coulson JM, Adams A, Gray LA, Evans A, et al. J Infect 2022 Jun 16. pii: S0163-4453(22)00363.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Coulson JM, Adams A, Gray LA, Evans A, et al. COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy. J Infect 2022 Jun 16. pii: S0163-4453(22)00363.
PMID: 35718206